CJA-73739-91196
4 vaccinations
7 coded responses
53 check-ins
7 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 303 / GA
- Registered
- 2021-01-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-09
Registered in v-safe
-
2021-01-09
Dose 1 — Pfizer-BioNTech
- 2021-01-09
-
2021-01-10
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-01-11
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-01-12
Survey response — days 1–6 daily, dose 1MedDRA: Disturbance in attention, Fatigue, Impaired work ability — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: Fatigue was initially moderate and made it extremely difficult to concentrate at work, but faded to be more mildMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-23
-
2021-01-30
Dose 2 — Pfizer-BioNTech
- 2021-01-30
-
2021-01-31
Survey response — days 1–6 daily, dose 2MedDRA: Presyncope, Tachycardia, Tremor — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Shakiness, high resting heart rate, 1 near-syncope episodeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-13
- 2021-02-20
- 2021-02-27
- 2021-03-06
- 2021-03-13
- 2021-05-01
- 2021-07-31
-
2021-10-01
Dose 3 — Pfizer-BioNTech
- 2021-10-01
-
2021-10-02
Survey response — days 1–6 daily, dose 3MedDRA: Arthralgia, Myalgia, Tachycardia — Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Joint and muscle pain located in lower extremities, but none in upper extremities. Some mild tachycardia.MedDRA releases: 2024-11 · check-in free text available
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-06
- 2021-10-07
- 2021-10-08
- 2021-10-15
- 2021-10-22
- 2021-10-29
- 2021-11-05
- 2021-11-12
- 2021-12-31
- 2022-04-01
-
2022-09-16
Dose 4 — Pfizer-BioNTech
-
2022-09-17
Survey response — days 1–6 daily, dose 4MedDRA: Tachycardia — Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tirednessFree text: TachycardiaMedDRA releases: 2024-11 · check-in free text available
-
2022-09-18
Survey response — days 1–6 daily, dose 4MedDRA: Lymph node pain — Feeling: Good · Site: Pain, Redness, SwellingFree text: Pain in axillary lymph node area on same side as injection siteMedDRA releases: 2024-11 · check-in free text available
-
2022-09-19
Survey response — days 1–6 daily, dose 4MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Pain, SwellingFree text: Swollen and painful left axillary lymph nodeMedDRA releases: 2024-11 · check-in free text available
-
2022-09-20
Survey response — days 1–6 daily, dose 4MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: SwellingFree text: Swollen and slightly painful left axillary lymph nodeMedDRA releases: 2024-11 · check-in free text available
- 2022-09-21
- 2022-09-22
- 2022-09-23
- 2022-09-30
- 2022-10-07
- 2022-10-14
- 2022-10-22
- 2022-10-29
- 2022-12-16
- 2023-03-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-09 | Pfizer-BioNTech | |
| 2 | 2021-01-30 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | No |
| 4 | 2022-09-16 | Pfizer-BioNTech | No |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Fatigue was initially moderate and made it extremely difficult to concentrate at work, but faded to be more mild
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Shakiness, high resting heart rate, 1 near-syncope episode
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Joint and muscle pain located in lower extremities, but none in upper extremities. Some mild tachycardia.
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Tachycardia
Systemic reaction (other): Pain in axillary lymph node area on same side as injection site
Systemic reaction (other): Swollen and painful left axillary lymph node
Systemic reaction (other): Swollen and slightly painful left axillary lymph node
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Arthralgia | · | · | ✓ |
| SRO | Disturbance in attention | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Impaired work ability | ✓ | ✓ | ✓ |
| SRO | Lymph node pain | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | Myalgia | · | · | ✓ |
| SRO | Presyncope | ✓ | ✓ | ✓ |
| SRO | Tachycardia | ✓ | ✓ | ✓ |
| SRO | Tremor | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release